Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-27

Clinical Trial Update: GOLO Open-Label Pilot 1 [NA]

View source ↗

Summary

GOLO's open-label pilot trial in Type 2 diabetes has completed; this update provides status with no results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GOLO

Snippet

Sponsor: Golo | Conditions: Diabetes Mellitus, Type II | NA | Status: COMPLETED